Michelle Cuccia
Sales & Marketing at ENZYMOTEC LTD.
Profile
Michelle Cuccia is currently the Chief Executive Officer at VAYA Pharma, Inc. and Vice President-Marketing at Enzymotec Ltd.
She previously worked as Vice President-Marketing at Teva Pharmaceutical Industries Ltd.
Ms. Cuccia has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.
Michelle Cuccia active positions
Companies | Position | Start |
---|---|---|
ENZYMOTEC LTD. | Sales & Marketing | 2017-07-31 |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of International Flavors & Fragrances, Inc., VAYA Pharma, Inc. engages in the discovery, development, manufacture and marketing of natural lipids based medicines. The company is based in Baltimore, MD. Michelle Cuccia has been the CEO of the company since 2017. | Chief Executive Officer | 2017-07-31 |
Former positions of Michelle Cuccia
Companies | Position | End |
---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Sales & Marketing | - |
Training of Michelle Cuccia
The Trustees of Columbia University in The City of New York | Graduate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private companies | 2 |
---|---|
Enzymotec Ltd.
Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of International Flavors & Fragrances, Inc., VAYA Pharma, Inc. engages in the discovery, development, manufacture and marketing of natural lipids based medicines. The company is based in Baltimore, MD. Michelle Cuccia has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Michelle Cuccia